Eli Lilly To Pay Whistleblower $61M For False Claims Act Violations
A federal grand jury ordered Eli Lilly to pay more than $61 million to a former executive of a network of regional drug wholesalers over allegations the drug manufacturer underpaid rebates required under the Medicaid Drug Rebate Program. Under the Medicaid Drug Rebate Program, the rebates drugmakers must pay are Read More